Literature DB >> 23342931

Symptom burden and infection occurrence among individuals with extremity lymphedema.

S H Ridner1, J Deng, M R Fu, E Radina, S R J Thiadens, J Weiss, M S Dietrich, J N Cormier, C M Tuppo, J M Armer.   

Abstract

Currently, there is a lack of data related to differences in symptoms and infection across different types and anatomical sites of lymphedema. The objective of this study was to examine differences in symptoms and infection status among individuals with lymphedema of the upper or lower extremities. The National Lymphedema Network initiated an online survey of self-report lymphedema data from March 2006 through January 2010. Descriptive statistics, Mann-Whitney tests, and Chi-square tests were used to analyze data. 723 individuals with upper extremity lymphedema and 1114 individuals with lower extremity lymphedema completed the survey. Individuals with extremity lymphedema experienced high symptom burden and infectious complications. Compared with individuals with upper extremity lymphedema, individuals with lower extremity lymphedema experienced more frequent and more severe symptoms (p<.001), infection episodes (p<.001), and infection-related hospitalizations (p<.001). No statistically significant differences of symptom burden and infection status were identified between individuals with lower extremity primary and secondary lymphedema. Individuals with extremity lymphedema experience substantial symptom burden and infectious complications; however, those with lower extremity lymphedema have more severe symptoms and more infections than those with upper extremity lymphedema.

Entities:  

Mesh:

Year:  2012        PMID: 23342931

Source DB:  PubMed          Journal:  Lymphology        ISSN: 0024-7766            Impact factor:   1.286


  12 in total

1.  Differences of symptoms in head and neck cancer patients with and without lymphedema.

Authors:  Jie Deng; Barbara A Murphy; Mary S Dietrich; Robert J Sinard; Kyle Mannion; Sheila H Ridner
Journal:  Support Care Cancer       Date:  2015-08-29       Impact factor: 3.603

Review 2.  Manual lymphatic drainage for lymphedema following breast cancer treatment.

Authors:  Jeanette Ezzo; Eric Manheimer; Margaret L McNeely; Doris M Howell; Robert Weiss; Karin I Johansson; Ting Bao; Linda Bily; Catherine M Tuppo; Anne F Williams; Didem Karadibak
Journal:  Cochrane Database Syst Rev       Date:  2015-05-21

Review 3.  Chronic oedema/lymphoedema: under-recognised and under-treated.

Authors:  David H Keast; Marc Despatis; Jill O Allen; Alain Brassard
Journal:  Int Wound J       Date:  2014-02-12       Impact factor: 3.315

Review 4.  Breast cancer-related lymphedema: Symptoms, diagnosis, risk reduction, and management.

Authors:  Mei R Fu
Journal:  World J Clin Oncol       Date:  2014-08-10

5.  Doxorubicin Activates Ryanodine Receptors in Rat Lymphatic Muscle Cells to Attenuate Rhythmic Contractions and Lymph Flow.

Authors:  Amanda J Stolarz; Mustafa Sarimollaoglu; John C Marecki; Terry W Fletcher; Ekaterina I Galanzha; Sung W Rhee; Vladimir P Zharov; V Suzanne Klimberg; Nancy J Rusch
Journal:  J Pharmacol Exp Ther       Date:  2019-08-22       Impact factor: 4.030

6.  A Prospective Study on the Safety and Efficacy of Vascularized Lymph Node Transplant.

Authors:  Stav Brown; Babak J Mehrara; Michelle Coriddi; Leslie McGrath; Michele Cavalli; Joseph H Dayan
Journal:  Ann Surg       Date:  2022-07-15       Impact factor: 13.787

7.  Complexities of Adherence and Post-Cancer Lymphedema Management.

Authors:  Pamela L Ostby; Jane M Armer
Journal:  J Pers Med       Date:  2015-11-16

Review 8.  Patient-Reported Outcome Measures With Secondary Lower Limb Lymphedemas: A Systematic Review.

Authors:  Margit Eidenberger
Journal:  J Adv Pract Oncol       Date:  2021-03-01

9.  Dantrolene Prevents the Lymphostasis Caused by Doxorubicin in the Rat Mesenteric Circulation.

Authors:  Serena Van; Soumiya Pal; Brittney R Garner; Kate Steed; Vijayalakshmi Sridharan; Shengyu Mu; Nancy J Rusch; Amanda J Stolarz
Journal:  Front Pharmacol       Date:  2021-08-16       Impact factor: 5.810

Review 10.  Histopathologic Features of Lymphedema: A Molecular Review.

Authors:  Claire Y Li; Raghu P Kataru; Babak J Mehrara
Journal:  Int J Mol Sci       Date:  2020-04-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.